the board of directors for mei pharma has rejected a buyout proposal from stockholders anson funds management and cable car capital mei pharma said its board concluded that the unsolicited bid which sought to buy all outstanding shares for 8 apiece significantly undervalued the pharmaceutical company and is less appealing